ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1790

Targeted Ablation of Knee-innervating Nociceptors Attenuates Pain and Cartilage Degeneration in Experimental Osteoarthritis

Lai Wang1, alia obeidat2, Shingo Ishihara3, Jun Li2, Frank Ko2, Terese Geraghty2, Natalie Adamczyk3, Sarah Soorya2, Richard Miller4, Rachel Miller1 and Anne-Marie Malfait2, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Chicago, 3Rush University, Chicago, 4Northwestern University, Chicago

Meeting: ACR Convergence 2025

Keywords: cartilage, Mouse Models, Other, Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1780–1808) Osteoarthritis & Joint Biology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Nociceptors abundantly innervate the knee joint. In experimental osteoarthritis (OA), nociceptors sprout in the medial synovium and in subchondral bone channels. We aimed to determine the effect of selective ablation of knee-innervating nociceptors in murine OA.

Methods: Adeno-associated virus AAV.PHP.S carrying diphtheria toxin A (dtA) (AAV-dtA) or control AAV (AAV-Ctrl) was injected intra-articularly (i.a.) into the knee cavity of 7-week old male NaV1.8-Cre mice. Destabilization of the medial meniscus (DMM) or sham surgery were performed 3 weeks later. Pain-related behaviors (weight bearing and knee hyperalgesia) were assessed up to 16 weeks after surgery. Knee joints were collected for histology, microCT, innervation analysis, and protein antibody array. Lumbar dorsal root ganglia (DRG) were collected for immunofluorescence staining or qPCR analysis.

Results: Injection of AAV-dtA effectively ablated joint nociceptors. This had no effect on knee hyperalgesia but attenuated weight bearing deficits (Fig. 1A-B), with decreased Ccl2 in DRG (Fig. 1C). AAV-dtA administration suppressed nociceptor sprouting in subchondral bone channels (Fig. 1D), but not in the medial synovium (Fig. 1E). Marked cartilage damage observed in AAV-Ctrl injected joints was attenuated in AAV-dtA injected mice (Fig. 2A), while synovitis, osteophytes, and microCT of the subchondral bone were similar in both groups. Knee joint lysates showed lower levels of calcitonin gene-related peptide (CGRP) 4 and 8 weeks after DMM in AAV-dtA injected mice (Fig. 2B), as well as decreased pro-inflammatory factors 8 weeks after DMM and increased levels of cartilage-anabolic markers 16 weeks after DMM (Fig. 2C). CGRP+ neurons were also decreased in ipsilateral lumbar DRGs, along with reduced NaV1.8+ neurons after ablation.

Conclusion: Knee-innervating nociceptor ablation before DMM attenuated weight bearing asymmetry, subchondral bone nerve sprouting, and cartilage degeneration. Cartilage anabolic factors were increased in the joints, while CGRP levels were decreased. The neurogenic contribution to OA may result from the neuropeptides released from nerve endings in early stages of OA.

Supporting image 1Fig. 1. Pain behavioral tests and knee joint innervation analysis in DMM mice with IA NaV1.8+ neuron ablation. (A) Weight bearing tests. (B) Knee hyperalgesia tests. (C) Expression of pro-algesic Ccl2 mRNA in ipsilateral L3-L5 DRG. (D, E) Nerve sprouting in subchondral bone (D) and medial synovium (E) was analyzed with IF staining of a pan-neuronal marker TUBB3.

Supporting image 2Fig. 2. Knee joint histopathological analysis and joint lysate protein analysis of DMM mice with intra-articular NaV1.8+ neuron ablation. (A) Representative images of medial compartments of mouse knee sections stained with toluidine blue. Cartilage degeneration and osteophyte formation were evaluated using a modified OARSI scoring system. (B) ELISA assay of CGRP protein in DMM knee joint lysates. (C) Antibody arrays of DMM knee joint lysates (Quantibody® Mouse Cytokine Antibody Array, RayBiotech).


Disclosures: L. Wang: None; a. obeidat: None; S. Ishihara: None; J. Li: None; F. Ko: None; T. Geraghty: None; N. Adamczyk: None; S. Soorya: None; R. Miller: None; R. Miller: None; A. Malfait: Asahi Kasei Pharma Corporation, 23andMe, Orion, 2.

To cite this abstract in AMA style:

Wang L, obeidat a, Ishihara S, Li J, Ko F, Geraghty T, Adamczyk N, Soorya S, Miller R, Miller R, Malfait A. Targeted Ablation of Knee-innervating Nociceptors Attenuates Pain and Cartilage Degeneration in Experimental Osteoarthritis [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/targeted-ablation-of-knee-innervating-nociceptors-attenuates-pain-and-cartilage-degeneration-in-experimental-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeted-ablation-of-knee-innervating-nociceptors-attenuates-pain-and-cartilage-degeneration-in-experimental-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology